[144] Confluent, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Confluent, Inc. (CFLT) reports a proposed sale of 243,200 common shares with an aggregate market value of $4,922,368.00. The sale is to be executed on 09/09/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The securities were acquired and paid for on 09/09/2025 by exercise of stock options from the issuer, with payment in cash. The filing indicates no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Insights

Financial Analyst

TL;DR Routine nondiscretionary filing disclosing a post-exercise sale of common shares through a broker.

The Form 144 documents a proposed sale of 243,200 Confluent common shares valued at $4.92 million to be executed through Morgan Stanley Smith Barney on NASDAQ on 09/09/2025. The shares were acquired via exercise of stock options and paid in cash the same day. There are no reported sales in the prior three months. From a market-impact perspective this is a disclosed, brokered transaction that provides transparency into an insider-derived sale; the filing itself contains no operational or financial performance data.

Corporate Governance Expert

TL;DR Proper insider sale disclosure consistent with Rule 144; procedural compliance is evident.

The notice includes required elements: number of shares, aggregate market value, broker name and address, acquisition method (option exercise), payment method (cash), and planned sale date. The filer affirms absence of undisclosed material information and reports no prior sales in three months. This filing reflects standard compliance with transfer reporting obligations rather than signaling governance changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	243200	4922368.00	291931187	09/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/09/2025	Exercise of Stock Options	Issuer			243200	09/09/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Confluent (CFLT) disclose?

It discloses a proposed sale of 243,200 common shares valued at $4,922,368.00, to be sold on 09/09/2025 on NASDAQ through Morgan Stanley Smith Barney LLC.

How were the Confluent shares acquired that are being sold?

The shares were acquired on 09/09/2025 by exercise of stock options from the issuer, with payment made in cash on that date.

Does the filing report any securities sold in the past three months by the seller?

The filing states 'Nothing to Report' for securities sold during the past three months.

Who is the broker handling the proposed sale?

The broker is Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor, New York, NY 10004.

What representation does the filer make about material information?

The filer represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.